Latest News
Replimune Surges 107% as FDA Panel Backs RP1 Despite Data Discrepancies
Replimune shares soared 107% after an FDA panel endorsed RP1's efficacy data, despite conflicting response rates. The FDA decision is expected by August 2.
Integer Holdings Soars 20% on KKR Takeover Speculation
Integer Holdings jumped 20% on reports that KKR is in advanced talks to acquire the medical device maker for around $127 per share, leaving a narrow spread for investors.
SoundHound AI Faces Steep Revenue Hurdle Ahead of Q2 Earnings
SoundHound AI shares closed unchanged ahead of Q2 earnings. Analysts expect $52.38M revenue, but the company must nearly double that to meet guidance.
Supermicro's Q4 Margin Forecasts Signal Up to 84% Gross Profit Surge
Supermicro (SMCI) sees Q4 gross profit rising 62%-84% to $1.65B-$1.87B on ~$11B revenue, driven by record orders. Shares gained 2.4% Friday.
Pfizer Stock Climbs Ahead of Q2 Earnings on Strong Eliquis Sales Signal
Pfizer shares gained 2% this week ahead of Q2 earnings, bolstered by partner Bristol Myers' strong Eliquis sales and raised 2026 outlook.
Linde Stock Drops 6% as Capex Hike Outpaces EPS Growth
Linde shares dropped 5.9% after the company boosted 2026 capital spending guidance by 9.5% while EPS guidance rose just 0.3%, signaling a shift toward capital intensity.
AMC Stock Slips Despite Record Spider-Man Preview and Dilution Concerns
AMC shares dipped to $2.76 despite a record $72M Spider-Man preview. A 74% increase in share count weighs on valuation.